Sublingual Immunotherapy

Publication Date: May 1, 2017

Key Points

Key Points

  • It is crucial that the practicing allergist separate the data on FDA reviewed products that have led to approval of these products (ie, dust mites, grass and ragweed tablets) from the data in the literature with other allergens and other formulations (eg, liquid formulations) that have not undergone the rigor of FDA review.

Diagnosis

...gnosis...

.... World Allergy Organization Grading System for...


...tion of Local Adverse Effects Related...


Treatment

...reatment

...y FDA-approved SLIT products for the treatment o...


...should be aware that SLIT may not be su...


...ved SLIT products very cautiously in...


...dosing equivalence between SLIT tablets and ex...


...inister the patient’s first dose of SLIT in a me...


...epinephrine (either an autoinjector or oth...


...tient’s SLIT dose if they have missed tre...


...patients receiving SLIT therapy for regular follow...


...products for SLIT in the United States are the 5...


...able 3. Suggested Guidelines for the Prac...


...able 4. FDA-Approved Sublingual Tab...